
pmid: 18869358
SummaryFrom the small series of animals receiving oral bacitracin, the following significant facts were obtained: 1. Fecal streptococci and spore forming anaerobes were greatly reduced in the intestine at a dosage between 2,000 and 10,000 u/kg per day. 2. Coliform organisms were little affected by bacitracin. 3. Bacitracin persisted in the feces as long as 3 days following cessation of treatment. 4. Bacitracin was absorbed from the intestinal tract as evidenced by significant blood levels. 10,000 u/kg per day was sufficient to produce blood levels as high as 0.085 u/cc of plasma 1 hour after administration. 5. Additional evidence of absorption was obtained by the finding of high levels of bacitracin in the urine. The highest obtained with 10,000 u was 0.22 u/cc and with 20,000 u 1.65 u/cc of urine.
Bacitracin, Administration, Oral, Humans
Bacitracin, Administration, Oral, Humans
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 18 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
